| __timestamp | Amneal Pharmaceuticals, Inc. | Incyte Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 785623000 | 511495000 |
| Thursday, January 1, 2015 | 866280000 | 753751000 |
| Friday, January 1, 2016 | 1018225000 | 1105719000 |
| Sunday, January 1, 2017 | 1033654000 | 1536216000 |
| Monday, January 1, 2018 | 1662991000 | 1881883000 |
| Tuesday, January 1, 2019 | 1626373000 | 2158759000 |
| Wednesday, January 1, 2020 | 1992523000 | 2666702000 |
| Friday, January 1, 2021 | 2093669000 | 2986267000 |
| Saturday, January 1, 2022 | 2212304000 | 3394635000 |
| Sunday, January 1, 2023 | 2393607000 | 3695649000 |
Infusing magic into the data realm
In the competitive landscape of pharmaceuticals, revenue growth is a key indicator of success. From 2014 to 2023, Incyte Corporation and Amneal Pharmaceuticals, Inc. have been on a fascinating revenue journey. Incyte Corporation has seen a remarkable growth trajectory, with its revenue increasing by over 620% from 2014 to 2023. In contrast, Amneal Pharmaceuticals, Inc. has experienced a steady growth of approximately 205% over the same period.
In 2014, Amneal led with a revenue of $786 million, but by 2023, Incyte had surged ahead, reaching nearly $3.7 billion, compared to Amneal's $2.4 billion. This shift highlights Incyte's strategic advancements and market positioning. As the pharmaceutical industry continues to evolve, these companies exemplify the dynamic nature of revenue growth and competition.
Amgen Inc. or Incyte Corporation: Who Leads in Yearly Revenue?
Gilead Sciences, Inc. vs Amneal Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Alnylam Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Incyte Corporation and Walgreens Boots Alliance, Inc.: A Comprehensive Revenue Analysis
Gross Profit Analysis: Comparing Incyte Corporation and Amneal Pharmaceuticals, Inc.
Incyte Corporation or MorphoSys AG: Who Leads in Yearly Revenue?
Incyte Corporation and Vericel Corporation: A Comprehensive Revenue Analysis
Exelixis, Inc. and Amneal Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc. Performance Compared
Amneal Pharmaceuticals, Inc. vs MorphoSys AG: Examining Key Revenue Metrics
Revenue Showdown: Amneal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Revenue Insights: Amneal Pharmaceuticals, Inc. and Novavax, Inc. Performance Compared